Meta PixelGallbladder Polyp Cancer Risk: When Surgery Is Needed

Not Every Gallbladder Polyp Needs Surgery: Reading the Cancer Risk

Medically reviewed by Dr. Michael Kachur · Frankfurt, Germany·

An ultrasound comes back and the report mentions a polyp in your gallbladder. The word polyp sits close to the word growth, and the mind jumps to cancer. But the large majority of gallbladder polyps are not cancer, and most never will be. Many are not even true tumors. They are cholesterol deposits that sit quietly for years. The real question is not whether you have a polyp. It is how big it is, and whether it is the same size next year. Reading that trend, not the single snapshot, is the kind of work Healz was built to do.

Category
Health Insights
Date
Reading time
10 min
Share

The polyp on today's scan is rarely the whole story. What matters is its size, its shape, a few risk factors, and above all what it does over time. Get those right and most people land in simple ultrasound follow-up, not the operating room. Miss them and a small polyp that was slowly growing gets filed next to a harmless one.

Not Every Gallbladder Polyp Needs Surgery: Reading the Cancer Risk

Why a polyp on your gallbladder is usually not the emergency it feels like

Gallbladder polyps are found by accident far more often than they are looked for. They turn up on ultrasounds ordered for something else entirely, right-sided pain, gallstones, an unrelated abdominal complaint. A polyp is reported on somewhere between about 1.3 and 9.5 percent of abdominal ultrasounds, and most people carrying one have no symptoms at all (StatPearls). Mayo Clinic makes the same point plainly: gallbladder polyps are common, and most are not cancer.

That is the first thing to hold onto when the report puts the word polyp near the word gallbladder. Commonness cuts both ways. It means the finding is usually harmless, and it means the system for sorting the harmless majority from the small worrisome minority has to be precise. The goal is not to remove every gallbladder. It is to identify the few polyps that are truly neoplastic, or that are changing, and act only on those. Like any incidental finding, the right move is a measured next step, not panic and not silence.

Ask Healz.

One chat instead of ten apps. 1M+ rare cases checked. The root cause, not the label. Private.

The types, and why most carry little to no risk

Not every polyp is the same lesion, and the type carries most of the risk information. The word polyp on an ultrasound simply means a bump projecting from the gallbladder wall. What it is made of decides everything.

  • Cholesterol polyps. These are by far the most common, accounting for roughly 60 to 70 percent of gallbladder polyps, and they have no inherent malignant potential (Society of Radiologists in Ultrasound). They are cholesterol deposits in the lining, not tumors. Most polyps smaller than 10 mm are this kind.
  • Inflammatory and other pseudopolyps. These form from inflammation, carry close to a zero risk of cancer, rarely grow beyond 1 cm, and are often multiple (Society of Radiologists in Ultrasound). Like cholesterol polyps, they are not neoplasia.
  • Adenomyomatosis. A benign overgrowth of the gallbladder wall that can mimic a polyp on ultrasound. It is not cancer, though it sometimes needs a closer look to tell apart.
  • Adenomas. True neoplastic polyps are the uncommon minority, and they are the ones that can, through an adenoma-to-carcinoma sequence, turn into gallbladder cancer over time. Size and a few features are what flag them.

The single most useful division is pseudopolyp versus true neoplasm. Cholesterol and inflammatory polyps, the great majority, carry essentially no cancer risk; the rare adenoma is where the malignant potential lives. This is why the whole workup bends toward one question first: does this polyp have the size or the features that make a true neoplasm likely.

The 10 mm threshold, and what else raises the risk

Type is the frame, but on a single ultrasound you cannot always see the type directly. Size is the stand-in that carries the most risk information, and 10 mm is the number that matters. A polyp 10 mm or smaller carries a cancer risk well under 1 percent, while the risk climbs steeply as size passes 10 mm, and again past 15 and 20 mm (systematic review and meta-analysis). Size is, by consensus, the single most important predictor of malignancy.

Size does not act alone. Several other features shift the call, and they are why a 7 mm polyp in one person is watched while a 7 mm polyp in another is removed. The ESGAR joint guideline names them: a sessile shape, meaning a broad flat base rather than a stalk, age over 60, primary sclerosing cholangitis, Asian or Indian ethnicity, and focal thickening of the gallbladder wall beyond 4 mm. A polyp that is solitary rather than one of many also leans toward neoplastic. And change over time matters as much as any single feature: growth of 2 mm or more within the two-year follow-up window is itself a reason to move toward surgery (ESGAR joint guideline).

None of these is a diagnosis on its own. A 12 mm cholesterol polyp is still benign, and a sessile polyp is not automatically cancer. The features matter because of what they suggest about the odds of a true neoplasm, which is why they are read together, in context, not as a checklist of alarms.

Watch or remove: the surveillance-versus-surgery call

For most polyps, the answer is neither surgery nor a shrug. It is a schedule. The primary tool throughout is transabdominal ultrasound, the same test that found the polyp, because it shows size and shape without radiation (ESGAR joint guideline).

Under the European ESGAR joint guideline, a polyp 10 mm or larger prompts a recommendation for cholecystectomy in a patient fit for and accepting surgery. A polyp of 6 to 9 mm with at least one risk factor, such as age over 60, primary sclerosing cholangitis, a sessile shape, or Asian or Indian ethnicity, is also steered toward surgery. Everything else, a 6 to 9 mm polyp with no risk factors, or a polyp 5 mm or smaller even with risk factors, is followed with ultrasound at 6 months, 1 year, and 2 years, with follow-up stopped after 2 years if the polyp has not grown.

The US-focused Society of Radiologists in Ultrasound consensus draws the lines a little more conservatively, and it sorts polyps first by shape, then by size. For a low-risk (sessile) polyp, it recommends no follow-up at all at 6 mm or smaller, a single ultrasound at 12 months for a 7 to 9 mm polyp, ultrasound at 6, 12, 24, and 36 months for a 10 to 14 mm polyp, and a surgical consultation for a polyp 15 mm or larger. The honest tension in this field is that the guidelines disagree at the margins, and neither is perfect, which is exactly why the decision rests on the full picture of size, shape, risk factors, and change over time rather than any single number. When the impression on your ultrasound report gives a polyp size, that number is the start of the conversation, not the end of it.

How Healz reads a gallbladder polyp in context

A gallbladder polyp is not one measurement to react to. It is a size, a shape, and above all a trend. Reading it well means seeing the ultrasounds in sequence, not one at a time. Healz keeps your whole case in one place, one chat instead of ten portals, so every ultrasound report and every measurement sit together the moment you upload them.

Healz has memory that holds every prior ultrasound and connects them over time. A polyp measured at 6 mm two years ago and 9 mm today is read as growth, not as two unrelated snapshots, and growth is the exact signal the surveillance schedule exists to catch. That memory works alongside root-cause technology so nothing you upload is read in isolation.

Healz is equipped with Frontier AI and root-cause technology, which is why it does not stop at the word polyp. It reads the size against the 10 mm threshold, weighs shape and the risk factors that shift the call, and cross-checks the picture against 1M+ cases to separate a benign cholesterol polyp from the few that warrant surgery. Used as an AI lab report reader on your ultrasound report, or as a second opinion on your own imaging, it tells you which findings change the plan and which do not, and it is where an AI for cancer question gets read in full context instead of as a single scary line.

When you want a human in the loop, you can bring a board-certified doctor into the same chat for a second opinion.

Frequently asked questions

Are most gallbladder polyps cancerous?

No. The large majority of gallbladder polyps are benign, and most are not even true tumors. Cholesterol polyps, which have no malignant potential, make up roughly 60 to 70 percent of them, and inflammatory pseudopolyps carry close to zero cancer risk (Society of Radiologists in Ultrasound). The rare true neoplasm, an adenoma, is the one with malignant potential, and size and shape are what flag it.

When does a gallbladder polyp need to be removed?

Cholecystectomy is generally considered when a polyp reaches 10 mm or larger, when it grows rapidly on follow-up, or when it has a sessile shape or added risk factors such as age over 60 or primary sclerosing cholangitis (ESGAR joint guideline). A 6 to 9 mm polyp with a risk factor is also steered toward surgery. Below those thresholds, most polyps are simply watched.

How often should a gallbladder polyp be checked with ultrasound?

It depends on size and risk. The European ESGAR guideline follows a 6 to 9 mm polyp with ultrasound at 6 months, 1 year, and 2 years, stopping if it does not grow. The US Society of Radiologists in Ultrasound consensus recommends no follow-up for a polyp 6 mm or smaller, a single scan at 12 months for 7 to 9 mm, and closer surveillance for 10 to 14 mm. Any growth on these scans is a reason to reassess for surgery.

Does the size of a gallbladder polyp mean it is cancer?

No, but size is the strongest single predictor of risk. A polyp 10 mm or smaller carries a cancer risk well under 1 percent, while the odds rise sharply above 10 mm and higher still past 15 and 20 mm (systematic review and meta-analysis). A large polyp warrants attention, but even a polyp past the threshold can turn out to be a benign cholesterol lesion, which is why the whole picture is read together.

Most gallbladder polyps are not the emergency the word suggests. The answer is almost never to panic and almost never to ignore it. It is to know how big the polyp is, what shape it has, and whether it is the same size next year, then watch or act on that. Healz was built to read a polyp as a size and a trajectory, not a single scary word, so the harmless majority is reassured and the rare worrisome one is caught early.

Written by Healz Team · Filed under Health Insights

Your health deserves more than guesswork

Get a real investigation, not a symptom list. Root causes found, history remembered, dots connected.

Copyright 2026 Healz.aiHealzAI Inc · 1111B S Governors Ave #92123, Dover, DE 19904, USAMade with for better health